SickleInAfrica
SickleInAfrica is a grant-funded pan-African research consortium, headquartered at the University of Cape Town, that coordinates sickle cell disease research across eight African countries through three integrated initiatives (SADaCC, SPARCO, SPAN), serving researchers, clinicians, and patients.
- Company typePrivate
- Founded-
- HeadquartersCape Town, South Africa
- Headcount1–10
- GTM typeB2B
- OfferingServices
What SickleInAfrica does
SickleInAfrica is a pan-African sickle cell disease (SCD) research consortium headquartered at the University of Cape Town, South Africa, coordinating research activity across eight countries: Ghana, Mali, Nigeria, Tanzania, Uganda, Zambia, Zimbabwe, and South Africa. It is structured around three integrated initiatives—the Sickle Africa Data Coordinating Center (SADaCC) for centralized data management, the Sickle Pan-African Research Consortium (SPARCO) for clinical research across multiple sites, and the Sickle Cell Pan African Network (SPAN) for continental stakeholder engagement—with bioinformatics support provided by H3ABioNet.
The consortium's core technical assets include a Sickle Cell Disease Ontology Version 1.0, a standardized set of 1,499 SCD data elements organized through REDCap data instruments, SOPs, SCD registries with geographic mapping, grant-writing support materials, and a training curriculum delivered via workshops and webinars. These resources are provided at no cost to consortium members and the broader SCD research community.
SickleInAfrica does not operate as a commercial enterprise. It is funded through international research grants, and its go-to-market is community-led: coordinating researchers, clinicians, and institutions through online platforms, recurring training events, and face-to-face workshops. Primary users are SCD researchers, healthcare professionals, and—indirectly—patients with sickle cell disease in Africa. No pricing model, paying customers, or revenue mechanics exist; financial sustainability depends entirely on continued grant funding.
SickleInAfrica firmographics
Firmographics- Name
- SickleInAfrica
- Legal name
- SickleInAfrica
- Website
- https://sickleinafrica.org
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SickleInAfrica is a grant-funded pan-African research consortium, headquartered at the University of Cape Town, that coordinates sickle cell disease research across eight African countries through three integrated initiatives (SADaCC, SPARCO, SPAN), serving researchers, clinicians, and patients.
- Ownership category
- akta.pro rank
SickleInAfrica industry classification
Industry- Product category
- Biomedical Research Consortium
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
- akta.pro secondary industries
- Clinical Document & Data Exchange (C-CDA, CCD, Direct Messaging) (HLACABAI), HIE Platforms & Network Services (Community/Regional/National) (HLACABAB)
Keywords
Where SickleInAfrica is headquartered
LocationHeadquarters
- HQ city
- Cape Town
- HQ country
- South Africa
- HQ region
- Africa
Offices8 records
Markets served
SickleInAfrica business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Grant Funding: The consortium operates as a research network funded through international research grants and funding agencies to support sickle cell disease research across Africa
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
SickleInAfrica product offering
Product offeringCore offering
SickleInAfrica is a pan-African research consortium that coordinates Sickle Cell Disease (SCD) research and supports translation of research into healthcare outcomes across eight African countries. It operates through three integrated initiatives — SADaCC for data coordination, SPARCO for clinical research, and SPAN for stakeholder networking — and delivers standardized data infrastructure (REDCap-based data elements, SCD Ontology), training workshops, SCD registries, and grant and publication support to affiliated researchers and clinicians.
Product overview
SickleInAfrica is a consortium platform that facilitates Sickle Cell Disease (SCD) research in Africa and its translation into healthcare outcomes. The platform operates as a unified consortium comprising three interconnected initiatives: SADaCC (Sickle Africa Data Coordinating Center), SPARCO (Sickle Pan-African Research Consortium), and SPAN (Sickle Cell Pan African Network). The platform provides research infrastructure including the SCD Data Elements repository (1,499 REDCap-based data elements), the Sickle Cell Disease Ontology Version 1.0, publications, grant writing resources, SOPs/quizzes, SCD registries, workshops, and an external opportunities listing. The consortium serves as a coordination hub connecting researchers across African sites in Ghana, Mali, Tanzania, Nigeria, Uganda, Zambia, Zimbabwe, and South Africa.
Differentiator
Problem solved
Functional benefit
Products and services
- SickleInAfrica Consortium Pan-African research consortium uniting three initiatives (SADaCC, SPARCO, SPAN) to coordinate Sickle Cell Disease research and translate findings into healthcare outcomes across Africa. For SCD researchers, clinicians, and member institutions.
- SCD Data Elements Consolidated repository of 1,499 standardized sickle cell disease data elements organized around REDCap data instruments, made available to consortium researchers for cross-site data interoperability.
- Sickle Cell Disease Ontology Version 1.0 Standardized ontology for sickle cell disease terminology and concepts, hosted at scdontology.h3abionet.org, enabling consistent data definitions and interoperability across consortium sites.
- Sickle Cell Disease Registries SCD patient registries and maps documenting patient data and clinical research sites across African countries, supporting epidemiological studies and research participation.
Companies that use SickleInAfrica
Customer profileSegments3 records
Ideal customer profiles1 record
SickleInAfrica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
SickleInAfrica partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Sickle Africa Data Coordinating Center (SADaCC)coreSADaCC is one of the three core initiatives of the SickleInAfrica consortium, serving as the Data Coordinating Center. It is based at the University of Cape Town and provides centralized data management and coordination services for sickle cell disease research across Africa.
- Sickle Pan-African Research Consortium (SPARCO)coreSPARCO is a core initiative of the SickleInAfrica consortium focused on conducting pan-African sickle cell disease research. It operates clinical centers in multiple African countries including Ghana (Kumasi), Mali, Nigeria (Abuja), Tanzania (Muhimbili), Uganda, Zambia, and Zimbabwe.
- Sickle Cell Pan African Network (SPAN)coreSPAN is one of the three core initiatives of the SickleInAfrica consortium, focused on building pan-African networking and collaboration for sickle cell disease awareness, research, and healthcare improvement.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
SickleInAfrica competitors and assessment
Company assessmentDirect peers
- MalariaGEN: Consortium creating large-scale, standardized genomic data resources across African populations; highly comparable operating model (consortium, multi-country sites, shared data instruments, ontology-led harmonization) applied to malaria rather than SCD.
- H3Africa Consortium: Pan-African genomics research consortium coordinating data, training, and infrastructure across multiple African sites — the closest structural analog to SickleInAfrica's SADaCC/SPARCO/SPAN model and a known H3ABioNet partner ecosystem.
- H3ABioNet: Pan-African bioinformatics network providing data-handling and computational biology capacity to SickleInAfrica's training workshops; highly comparable because it shares the consortium model, African site footprint, and standardized-data tooling ethos.
Broad incumbents
- European Hematology Association (EHA): Hematology professional society that funds training and research mobility grants (some of which are listed on SickleInAfrica's external opportunities board); comparable in promoting SCD research and training, but at a pan-European rather than pan-African scale.
- NIH NHLBI Sickle Cell Disease Programs: The U.S. National Institutes of Health's primary funder and coordinator of SCD research (e.g., SCD Curative Therapies programs); comparable disease focus and registry/data infrastructure role, although primarily a funder rather than a peer consortium.
- American Society of Hematology (ASH) Research Collaborative: Operates hematology-focused data registries and clinical networks (including SCD) — directly comparable to SADaCC's data-coordination function, but backed by a broader, U.S.-anchored hematology society rather than an African consortium.
- Sickle Cell Disease Association of America (SCDAA): The longest-standing U.S.-based SCD advocacy, research, and patient-support organization; comparable disease-specific mission and audience (patients, clinicians, researchers) to SickleInAfrica, although U.S.-focused rather than Africa-focused.
Regional players
- Sickle Cell Foundation of Ghana: Ghana-based nonprofit supporting SCD awareness, screening, and patient services; operates in the same disease space as SickleInAfrica's Ghana SPARCo site and shares the West African SCD research and care mission.
Others
- ASH-EHA Translational Research Training in Hematology: Joint ASH-EHA training program in hematology that appears on SickleInAfrica's external opportunities page; comparable capacity-building function and audience of hematology/SCD researchers, with a U.S./European rather than African geographic focus.
Emerging players
- Global Alliance of Sickle Cell Disease Organizations (GASCDO): International umbrella of SCD-focused patient and research organizations; comparable audience and mission (awareness, research translation, capacity building) and acts as a potential distribution/coordination complement to SickleInAfrica.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
SickleInAfrica social profiles
Digital presenceSickleInAfrica financial estimates
Financial estimateRevenue estimate
Valuation estimate
SickleInAfrica leadership team
Management profileNumber of profiles
SickleInAfrica subsidiaries and ownership
Company hierarchySubsidiaries3 records
SickleInAfrica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SickleInAfrica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SickleInAfrica
What does SickleInAfrica do?
SickleInAfrica is a pan-African research consortium that coordinates Sickle Cell Disease (SCD) research and supports translation of research into healthcare outcomes across eight African countries. It operates through three integrated initiatives — SADaCC for data coordination, SPARCO for clinical research, and SPAN for stakeholder networking — and delivers standardized data infrastructure (REDCap-based data elements, SCD Ontology), training workshops, SCD registries, and grant and publication support to affiliated researchers and clinicians.
Is SickleInAfrica a public or private company?
SickleInAfrica is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was SickleInAfrica founded?
SickleInAfrica was founded in -1. It employs 1 to 10 people.
Where is SickleInAfrica based?
SickleInAfrica is headquartered in Cape Town, South Africa, in the Africa region.
How does SickleInAfrica make money?
One revenue line is on record: grant Funding.
Who are SickleInAfrica's main competitors?
Direct peers on record are MalariaGEN, H3Africa Consortium and H3ABioNet. Broad incumbents are European Hematology Association (EHA), NIH NHLBI Sickle Cell Disease Programs, American Society of Hematology (ASH) Research Collaborative and Sickle Cell Disease Association of America (SCDAA). Sickle Cell Foundation of Ghana is listed as a regional player. ASH-EHA Translational Research Training in Hematology is listed as an others. Global Alliance of Sickle Cell Disease Organizations (GASCDO) is listed as an emerging player.
Does SickleInAfrica have an API?
No public API is recorded for SickleInAfrica.
What industry is SickleInAfrica in?
SickleInAfrica's product category is Biomedical Research Consortium. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of HLACABAI, Clinical Document & Data Exchange (C-CDA, CCD, Direct Messaging). Its NAICS code is 5417 and its SIC code is 8731.